| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―10 |
SARS-CoV-2 variants: biology, pathogenicity, immunity and control |
Ryuta Uraki, Bette Korber, Michael S. Diamond, Yoshihiro Kawaoka |
| 2 |
[GO] |
2025―Oct―03 |
Viral emergence and pandemic preparedness in a One Health framework |
Reina S. Sikkema, Marion Koopmans |
| 3 |
[GO] |
2025―Jul―23 |
Emergence of pathogenic recombinant coronavirus in cats |
Shimona Starling |
| 4 |
[GO] |
2025―Jun―30 |
Phylogenetics and molecular evolution to understand and curb the HIV pandemic |
Huldrych F. Günthard, Katharina Kusejko, Roger D. Kouyos |
| 5 |
[GO] |
2025―May―14 |
To end the HIV-1 pandemic, concerted research efforts must focus on sub-Saharan Africa |
Monray E. Williams, Jaclyn K. Mann, Thumbi Ndung’u, Marius B. Tincho, Marcel Tongo, Ntobeko A. B. Ntusi, Thulani P. Makhalanyane |
| 6 |
[GO] |
2025―May―06 |
SARS-CoV-2 spike protein: structure, viral entry and variants |
Bing Chen, Michael Farzan, Hyeryun Choe |
| 7 |
[GO] |
2025―Feb―10 |
RNA evolution shapes SARS-CoV-2 success |
Agustina Taglialegna |
| 8 |
[GO] |
2024―Dec―11 |
Linking innate immune evasion to pandemic potential |
Lucy G. Thorne |
| 9 |
[GO] |
2024―Nov―25 |
The consequences of SARS-CoV-2 within-host persistence |
Alex Sigal, Richard A. Neher, Richard J. Lessells |
| 10 |
[GO] |
2024―Apr―15 |
COVID-19 drug discovery and treatment options |
Jasper Fuk-Woo Chan, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, Kwok-Yung Yuen |
| 11 |
[GO] |
2024―Jan―15 |
SARS-CoV-2 biology and host interactions |
Silvio Steiner, Annika Kratzel, G. Tuba Barut, Reto M. Lang, Etori Aguiar Moreira, Lisa Thomann, Jenna N. Kelly, Volker Thiel |
| 12 |
[GO] |
2023―Dec―19 |
Clinical course and management of COVID-19 in the era of widespread population immunity |
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, Victoria Male, Muge Cevik |
| 13 |
[GO] |
2023―Apr―17 |
Author Correction: Long COVID: major findings, mechanisms and recommendations |
Hannah E. Davis, Lisa McCorkell, Julia Moore Vogel, Eric J. Topol |
| 14 |
[GO] |
2023―Apr―05 |
The evolution of SARS-CoV-2 |
Peter V. Markov, Mahan Ghafari, Martin Beer, Katrina Lythgoe, Peter Simmonds, Nikolaos I. Stilianakis, Aris Katzourakis |
| 15 |
[GO] |
2023―Apr―03 |
SARS-CoV-2 rewires host chromatin |
Andrea Du Toit |
| 16 |
[GO] |
2023―Mar―17 |
Sewer biofilms and SARS-CoV-2 |
Andrea Du Toit |
| 17 |
[GO] |
2023―Feb―21 |
Early treatment for COVID-19 |
Andrea Du Toit |
| 18 |
[GO] |
2023―Feb―21 |
Coronavirus research: knowledge gaps and research priorities |
Stanley Perlman, Malik Peiris |
| 19 |
[GO] |
2023―Jan―19 |
SURFing SARS-CoV-2 inhibition |
Agustina Taglialegna |
| 20 |
[GO] |
2023―Jan―18 |
SARS-CoV-2 variant biology: immune escape, transmission and fitness |
Alessandro M. Carabelli, Thomas P. Peacock, Lucy G. Thorne, William T. Harvey, Joseph Hughes, Thushan I. de Silva, Sharon J. Peacock, Wendy S. Barclay, Thushan I. de Silva, Greg J. Towers, David L. Robertson |
| 21 |
[GO] |
2023―Jan―13 |
Long COVID: major findings, mechanisms and recommendations |
Hannah E. Davis, Lisa McCorkell, Julia Moore Vogel, Eric J. Topol |
| 22 |
[GO] |
2023―Jan―11 |
Innate immune evasion strategies of SARS-CoV-2 |
Judith M. Minkoff, Benjamin tenOever |
| 23 |
[GO] |
2022―Dec―02 |
SARS-CoV-2 viral load and shedding kinetics |
Olha Puhach, Benjamin Meyer, Isabella Eckerle |
| 24 |
[GO] |
2022―Nov―17 |
Ending the COVID-19 pandemic |
Michael Attwaters |
| 25 |
[GO] |
2022―Nov―02 |
SARS-CoV-2 variants offer a second chance to fix vaccine inequities |
Peter J. Hotez |
| 26 |
[GO] |
2022―Oct―28 |
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies |
MacGregor Cox, Thomas P. Peacock, William T. Harvey, Joseph Hughes, Derek W. Wright, Brian J. Willett, Emma Thomson, Ravindra K. Gupta, Sharon J. Peacock, David L. Robertson, Alessandro M. Carabelli |
| 27 |
[GO] |
2022―Oct―17 |
The effects of the COVID-19 pandemic on community respiratory virus activity |
Eric J. Chow, Timothy M. Uyeki, Helen Y. Chu |
| 28 |
[GO] |
2022―Oct―07 |
Histone mimicry by SARS-CoV-2 |
Ashley York |
| 29 |
[GO] |
2022―Aug―01 |
SARS-CoV-2 tunnels to new cells |
Ursula Hofer |
| 30 |
[GO] |
2022―Jun―14 |
Animal model of long COVID? |
Ursula Hofer |
| 31 |
[GO] |
2022―Mar―30 |
SARS-CoV-2 pathogenesis |
Mart M. Lamers, Bart L. Haagmans |
| 32 |
[GO] |
2022―Mar―25 |
Clotting and SARS-CoV-2 entry |
Ursula Hofer |
| 33 |
[GO] |
2022―Mar―14 |
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity |
Peter V. Markov, Aris Katzourakis, Nikolaos I. Stilianakis |
| 34 |
[GO] |
2022―Feb―23 |
Author Correction: Characteristics of SARS-CoV-2 and COVID-19 |
Ben Hu, Hua Guo, Peng Zhou, Zheng-Li Shi |
| 35 |
[GO] |
2022―Feb―18 |
Towards SARS-CoV-2 serotypes? |
Etienne Simon-Loriere, Olivier Schwartz |
| 36 |
[GO] |
2022―Feb―17 |
SARS-CoV-2 sensory loss |
Ashley York |
| 37 |
[GO] |
2022―Feb―04 |
Simulations of the spike: molecular dynamics and SARS-CoV-2 |
Conrado Pedebos, Syma Khalid |
| 38 |
[GO] |
2022―Jan―28 |
SARS-CoV-2 ‘super-permissive’ cells |
Ursula Hofer |
| 39 |
[GO] |
2022―Jan―13 |
Author Correction: Ecology, evolution and spillover of coronaviruses from bats |
Manuel Ruiz-Aravena, Clifton McKee, Amandine Gamble, Tamika Lunn, Aaron Morris, Celine E. Snedden, Claude Kwe Yinda, Julia R. Port, David W. Buchholz, Yao Yu Yeo, Christina Faust, Elinor Jax, Lauren Dee, Devin N. Jones, Maureen K. Kessler, Caylee Falvo, Daniel Crowley, Nita Bharti, Cara E. Brook, Hector C. Aguilar, Alison J. Peel, Olivier Restif, Tony Schountz, Colin R. Parrish, Emily S. Gurley, James O. Lloyd-Smith, Peter J. Hudson, Vincent J. Munster, Raina K. Plowright |
| 40 |
[GO] |
2021―Nov―19 |
Ecology, evolution and spillover of coronaviruses from bats |
Manuel Ruiz-Aravena, Clifton McKee, Amandine Gamble, Tamika Lunn, Aaron Morris, Celine E. Snedden, Claude Kwe Yinda, Julia R. Port, David W. Buchholz, Yao Yu Yeo, Christina Faust, Elinor Jax, Lauren Dee, Devin N. Jones, Maureen K. Kessler, Caylee Falvo, Daniel Crowley, Nita Bharti, Cara E. Brook, Hector C. Aguilar, Alison J. Peel, Olivier Restif, Tony Schountz, Colin R. Parrish, Emily S. Gurley, James O. Lloyd-Smith, Peter J. Hudson, Vincent J. Munster, Raina K. Plowright |
| 41 |
[GO] |
2021―Nov―19 |
SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs |
Sophie Belman, Senjuti Saha, Mathew A. Beale |
| 42 |
[GO] |
2021―Sep―28 |
Influenza lineage extinction during the COVID-19 pandemic? |
Marios Koutsakos, Adam K. Wheatley, Karen Laurie, Stephen J. Kent, Steve Rockman |
| 43 |
[GO] |
2021―Sep―17 |
Structural biology of SARS-CoV-2 and implications for therapeutic development |
Haitao Yang, Zihe Rao |
| 44 |
[GO] |
2021―Sep―07 |
Dose-dependent COVID-19 symptoms |
Ursula Hofer |
| 45 |
[GO] |
2021―Jun―18 |
Searching for relatives of SARS-CoV-2 in bats |
Ashley York |
| 46 |
[GO] |
2021―Jun―01 |
SARS-CoV-2 variants, spike mutations and immune escape |
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, Ravindra K. Gupta, Emma C. Thomson, Ewan M. Harrison, Catherine Ludden, Richard Reeve, Andrew Rambaut, Sharon J. Peacock, David L. Robertson |
| 47 |
[GO] |
2021―Apr―21 |
Blast from the past for coronavirus immunity |
Ursula Hofer |
| 48 |
[GO] |
2021―Apr―06 |
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract |
Tim Flerlage, David F. Boyd, Victoria Meliopoulos, Paul G. Thomas, Stacey Schultz-Cherry |
| 49 |
[GO] |
2020―Oct―28 |
Coronavirus biology and replication: implications for SARS-CoV-2 |
Philip V’kovski, Annika Kratzel, Silvio Steiner, Hanspeter Stalder, Volker Thiel |
| 50 |
[GO] |
2020―Oct―16 |
Learning from the past: development of safe and effective COVID-19 vaccines |
Shan Su, Lanying Du, Shibo Jiang |
| 51 |
[GO] |
2020―Oct―14 |
Considerations for diagnostic COVID-19 tests |
Olivier Vandenberg, Delphine Martiny, Olivier Rochas, Alex van Belkum, Zisis Kozlakidis |
| 52 |
[GO] |
2020―Oct―06 |
Characteristics of SARS-CoV-2 and COVID-19 |
Ben Hu, Hua Guo, Peng Zhou, Zheng-Li Shi |
| 53 |
[GO] |
2020―Sep―30 |
Detecting COVID-19 at the bedside |
Ursula Hofer, Andrea Du Toit, Ashley York |
| 54 |
[GO] |
2020―Sep―10 |
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa |
Emmanuel Margolin, Wendy A. Burgers, Edward D. Sturrock, Marc Mendelson, Rosamund Chapman, Nicola Douglass, Anna-Lise Williamson, Edward P. Rybicki |
| 55 |
[GO] |
2020―Jul―28 |
Rising to the challenge of COVID-19 |
Ursula Hofer, Andrea Du Toit, Ashley York |
| 56 |
[GO] |
2020―Jul―20 |
Can COVID-19 strike twice? |
Ashley York |
| 57 |
[GO] |
2020―Jun―19 |
Coronavirus replication factories |
Andrea Du Toit |
| 58 |
[GO] |
2020―Jun―02 |
Antimicrobial use, drug-resistant infections and COVID-19 |
Timothy M. Rawson, Damien Ming, Raheelah Ahmad, Luke S. P. Moore, Alison H. Holmes |
| 59 |
[GO] |
2020―May―15 |
A spike with which to beat COVID-19? |
Nawsad Alam, Matthew K. Higgins |
| 60 |
[GO] |
2020―Feb―12 |
Novel coronavirus takes flight from bats? |
Ashley York |
| 61 |
[GO] |
2020―Jan―27 |
Outbreak of a novel coronavirus |
Andrea Du Toit |
